A detailed history of Quadrant Capital Group LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Quadrant Capital Group LLC holds 15,131 shares of BSX stock, worth $1.49 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
15,131
Previous 14,943 1.26%
Holding current value
$1.49 Million
Previous $1.15 Million 10.17%
% of portfolio
0.09%
Previous 0.09%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$72.96 - $84.0 $13,716 - $15,792
188 Added 1.26%
15,131 $1.27 Million
Q2 2024

Aug 12, 2024

BUY
$67.33 - $77.71 $103,418 - $119,362
1,536 Added 11.46%
14,943 $1.15 Million
Q1 2024

May 15, 2024

BUY
$57.6 - $68.62 $2,822 - $3,362
49 Added 0.37%
13,407 $918,000
Q4 2023

Feb 08, 2024

BUY
$48.64 - $57.81 $10,749 - $12,776
221 Added 1.68%
13,358 $772,000
Q3 2023

Nov 14, 2023

BUY
$50.19 - $54.68 $61,984 - $67,529
1,235 Added 10.38%
13,137 $693,000
Q2 2023

Aug 09, 2023

SELL
$49.72 - $54.64 $1,441 - $1,584
-29 Reduced 0.24%
11,902 $643,000
Q1 2023

May 11, 2023

BUY
$45.09 - $50.03 $38,687 - $42,925
858 Added 7.75%
11,931 $596,000
Q4 2022

Feb 10, 2023

BUY
$39.56 - $47.22 $14,874 - $17,754
376 Added 3.52%
11,073 $512,000
Q3 2022

Nov 10, 2022

BUY
$36.71 - $109.66 $37,994 - $113,498
1,035 Added 10.71%
10,697 $414,000
Q2 2022

Aug 09, 2022

BUY
$35.24 - $47.1 $31,328 - $41,871
889 Added 10.13%
9,662 $360,000
Q1 2022

May 06, 2022

BUY
$40.9 - $45.1 $51,452 - $56,735
1,258 Added 16.74%
8,773 $388,000
Q4 2021

Feb 01, 2022

SELL
$38.07 - $44.87 $23,108 - $27,236
-607 Reduced 7.47%
7,515 $319,000
Q3 2021

Nov 12, 2021

BUY
$41.23 - $45.88 $7,751 - $8,625
188 Added 2.37%
8,122 $352,000
Q2 2021

Aug 09, 2021

BUY
$38.58 - $44.24 $27,700 - $31,764
718 Added 9.95%
7,934 $339,000
Q1 2021

May 12, 2021

BUY
$35.27 - $39.67 $30,684 - $34,512
870 Added 13.71%
7,216 $279,000
Q4 2020

Feb 16, 2021

SELL
$33.15 - $41.97 $41,570 - $52,630
-1,254 Reduced 16.5%
6,346 $228,000
Q3 2020

Nov 13, 2020

SELL
$34.44 - $42.23 $43,911 - $53,843
-1,275 Reduced 14.37%
7,600 $290,000
Q2 2020

Aug 13, 2020

SELL
$30.19 - $39.11 $26,567 - $34,416
-880 Reduced 9.02%
8,875 $312,000
Q1 2020

May 15, 2020

SELL
$25.83 - $45.71 $78,058 - $138,135
-3,022 Reduced 23.65%
9,755 $319,000
Q4 2019

Feb 03, 2020

BUY
$37.87 - $45.37 $58,925 - $70,595
1,556 Added 13.87%
12,777 $554,000
Q3 2019

Oct 24, 2019

BUY
$40.31 - $43.45 $149,388 - $161,025
3,706 Added 49.31%
11,221 $444,000
Q2 2019

Jul 24, 2019

SELL
$34.91 - $42.98 $52,120 - $64,169
-1,493 Reduced 16.57%
7,515 $311,000
Q1 2019

Apr 29, 2019

BUY
$32.91 - $40.75 $81,485 - $100,897
2,476 Added 37.91%
9,008 $334,000
Q4 2018

Jan 17, 2019

BUY
$31.73 - $39.04 $9,582 - $11,790
302 Added 4.85%
6,532 $215,000
Q2 2018

Aug 09, 2018

BUY
$26.84 - $34.32 $2,979 - $3,809
111 Added 1.81%
6,230 $193,000
Q1 2018

May 10, 2018

BUY
$25.2 - $28.54 $26,082 - $29,538
1,035 Added 20.36%
6,119 $158,000
Q2 2017

Aug 15, 2017

BUY
N/A
5,084
5,084 $106,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $141B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Quadrant Capital Group LLC Portfolio

Follow Quadrant Capital Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadrant Capital Group LLC with notifications on news.